Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatable gene expression systems for gene therapy applications: progress and future challenges.

S Goverdhana1, M Puntel, W Xiong

  • 1Department of Medicine, Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, David Geffen School of Medicine, University of California at Los Angeles, Davis Building, Room 5090, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|June 11, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microglial low-affinity FcγR mediates the phagocytic elimination of dopaminergic neurons in Parkinson's disease degeneration.

NPJ Parkinson's disease·2026
Same author

Lesion-associated microglia and macrophages mediate corralling and react with massive phagocytosis for debris clearance and wound healing after LPS-induced dopaminergic depletion.

Journal of neuroimmunology·2022
Same author

Neuroprotection of lipoic acid treatment promotes angiogenesis and reduces the glial scar formation after brain injury.

Neuroscience·2012
Same author

IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease.

Cell death & disease·2012
Same author

Evidence of oligodendrogliosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.

Neuropathology and applied neurobiology·2012
Same author

Nigral degeneration correlates with persistent activation of cerebellar Purkinje cells in MPTP-treated monkeys.

Histology and histopathology·2011
Same journal

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Endothelial injury with capillary leak: A final common pathway in acute AAV toxicity?

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Long-term functional synaptic integration of genome-edited retinal organoids in a primate model of macular degeneration.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Nox1/4 inhibitor Setanaxib treatment ameliorates cardiac function in mouse models of Duchenne Muscular Dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

HSP90α-USP7-DNMT1 Axis Drives Hepatocellular Carcinoma Recurrence After Microwave Ablation by Disrupting ACSS3-Mediated Propionate Metabolism.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
See all related articles
This summary is machine-generated.

Gene therapy requires precise control over gene expression. Developing safe and effective genetic switches is crucial for clinical applications, but challenges remain before human trials.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene therapy aims to correct disease phenotypes using viral and nonviral delivery systems.
  • Significant advancements have improved gene transfer efficiency, reduced toxicity, and enhanced long-term expression.
  • Clinical gene therapy success hinges on tightly regulating transgene expression when needed.

Purpose of the Study:

  • To review current regulatable systems for gene expression control in gene therapy.
  • To discuss gene transfer methods and preclinical models used for these systems.
  • To highlight remaining challenges for clinical translation of gene therapy switches.

Main Methods:

  • Literature review of gene therapy regulatable systems.
  • Analysis of gene transfer vehicles and preclinical applications.

Related Experiment Videos

  • Discussion of challenges in clinical implementation.

    • Main Results:

    • Various regulatable systems are under development, including tetracycline-dependent switches.
    • Some systems show success in preclinical in vivo models.
    • No regulatable gene expression systems have been used in human clinical trials yet.

    Conclusions:

    • Precise and consistent regulation of gene expression is vital for safe and effective gene therapy.
    • Development of non-toxic, tissue-penetrant compounds with specific half-lives is needed for on/off switching.
    • Overcoming immunological and regulatory hurdles is essential for clinical application of gene therapy switches.